Predictive Oncology announced that its wholly owned subsidiary Soluble Biotech Inc. just inked another contract with a large pharmaceutical company. The work will involve using Soluble Biotech’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destined for future clinical use.